RGS2 Antikörper (N-Term)
-
- Target Alle RGS2 Antikörper anzeigen
- RGS2 (Regulator of G-Protein Signaling 2 (RGS2))
-
Bindungsspezifität
- AA 4-32, N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RGS2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogen
- This RGS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 4-32 amino acids from the N-terminal region of human RGS2.
- Klon
- RB41808
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product RGS2 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Haltbarkeit
- 6 months
-
-
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).
: "Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma." in: Carcinogenesis, Vol. 31, Issue 10, pp. 1755-61, (2010) (PubMed).
: "
-
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).
-
- Target
- RGS2 (Regulator of G-Protein Signaling 2 (RGS2))
- Andere Bezeichnung
- RGS2 (RGS2 Produkte)
- Synonyme
- G0S8 antikoerper, GOS8 antikoerper, fa96c08 antikoerper, wu:fa96c08 antikoerper, wu:fj08f11 antikoerper, zgc:91965 antikoerper, g0s8 antikoerper, regulator of G protein signaling 2 antikoerper, regulator of G-protein signaling 2 antikoerper, regulator of G-protein signaling 2, 24kDa antikoerper, regulator of G-protein signaling 2 L homeolog antikoerper, RGS2 antikoerper, Rgs2 antikoerper, rgs2 antikoerper, rgs2.L antikoerper
- Hintergrund
- Regulator of G protein signaling (RGS) family members are regulatory molecules that act as GTPase activating proteins (GAPs) for G alpha subunits of heterotrimeric G proteins. RGS proteins are able to deactivate G protein subunits of the Gi alpha, Go alpha and Gq alpha subtypes. They drive G proteins into their inactive GDP-bound forms. Regulator of G protein signaling 2 belongs to this family. The protein acts as a mediator of myeloid differentiation and may play a role in leukemogenesis.
- Molekulargewicht
- 24382
- NCBI Accession
- NP_002914
- UniProt
- P41220
- Pathways
- Myometrial Relaxation and Contraction, Regulation of G-Protein Coupled Receptor Protein Signaling, Brown Fat Cell Differentiation
-